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Abstract Human MutT homologue (hMTH1) mRNA was
overexpressed in SV-40-transformed non-tumorigenic human
bronchial epithelial cells (BEAS-2B cells) and in 11 out of 12
human lung cancer cell lines relative to normal human bronchial
epithelial cells. Expression levels of hMTH1 mRNA were
inversely proportional to cellular levels of 8-oxo-deoxyguanosine.
Together, these results suggest that hMTH1 gene expression
may represent a molecular marker of oxidative stress that could
ultimately be used to elucidate the temporal relationships
between oxidative stress, genomic instability and the develop-
ment of lung cancer.
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1. Introduction
Reactive oxygen species (ROS) such as superoxide and hy-
drogen peroxide are continually formed in vivo by normal
cellular metabolism. Under normal conditions, the cell is
able to detoxify ROS via a number of pathways that utilize
chemical antioxidants (e.g. ascorbate, glutathione, K-toco-
pherol and uric acid) and/or antioxidant enzymes (e.g. cata-
lase, glutathione peroxidase and superoxide dismutase). Fol-
lowing exposure to exogenous toxicants such as air pollution,
cigarette smoke or radiation, cellular redox homeostasis may
be disrupted, resulting in oxidative stress, a condition charac-
terized by an increased £ux of ROS [1]. At elevated levels,
ROS may act as endogenous carcinogens by the following
mechanisms: (1) induction of oxidative DNA damage result-
ing in base-pair mutations or chromosome aberrations; (2)
activation of cytoplasmic or nuclear signal transduction path-
ways; and (3) modulation of stress genes that control e¡ector
genes related to cellular proliferation, di¡erentiation and
apoptosis [2].
One speci¢c modi¢cation of DNA linked to ROS is the
formation of 8-oxo-deoxyguanosine adducts (8-oxo-dG, also
known as 8-hydroxy-deoxyguanosine) resulting from attack of
either a hydroxyl radical or singlet oxygen on deoxyguanosine
[3]. Signi¢cantly elevated levels of 8-oxo-dG have been de-
tected in carcinomas of the breast [4], lung [5,6] and kidney
[7]. These data provide support for the hypothesis that DNA
of certain cancers is persistently exposed to a higher level of
oxidative stress than adjacent normal tissue [8]. However, the
use of 8-oxo-dG as a biomarker of oxidative stress has been
challenged because of the lack of consistency in its measure-
ment; levels detected in normal human cells have ranged from
6 0.1 to s 200 8-oxo-dG per 106 base pairs [9]. Therefore, a
more reliable molecular marker of oxidative stress in cancer is
needed.
Several enzymes have been identi¢ed in E. coli that act to
either remove 8-oxo-dG from DNA (MutM, MutY) [10] or
prevent incorporation of the oxidized free nucleotide (MutT)
[11]. Incorporation of 8-oxo-dG into DNA results in A:T to
C:G transversion mutations following DNA replication; the
bacterial mutT gene encodes an enzyme with 8-oxo-GTPase
activity that hydrolyzes 8-oxo-dGTP to 8-oxo-dGMP [11].
The human homologue of mutT, termed hMTH1, has been
cloned and localized to chromosome 7p [12]. To date, there
has only been one report in the literature relating hMTH1
expression and cancer; Okamato et al. [13] detected elevated
levels of hMTH1 mRNA in human renal cell carcinomas rel-
ative to adjacent non-tumorous kidney tissue. Further, they
found that advanced-stage tumors exhibit signi¢cantly higher
levels of hMTH1 mRNA relative to early-stage tumors, sug-
gesting the level of oxidative stress in renal cell carcinomas
increases with the stage of the disease. The purpose of the
current investigation was to extend the studies of Okamoto
et al. [13] to determine the relationship between hMTH1
mRNA expression and 8-oxo-dG levels in lung cancer.
2. Materials and methods
2.1. Cell culture
Normal human bronchial epithelial (NHBE) cells (strains 2129 and
4501) and bronchial epithelial cell growth medium (BEGM) were
purchased from Clonetics (San Diego, CA). Non-tumorigenic human
bronchial epithelial cells immortalized by transfection with SV40 virus
(BEAS-2B cells) were obtained from Dr. Curtis C. Harris at the Na-
tional Cancer Institute. The following lung cancer cell lines were pur-
chased from ATCC (Rockville, MD): A427 (adenocarcinoma, AC);
A549 (AC); Calu-3 (AC); SKLU-1 (AC); Calu-6 (anaplastic carcino-
ma, APC); Calu-1 (epidermoid carcinoma, EC); NCI-H82 (small cell
lung cancer, SC); NCI-H128 (SC); NCI-H209 (SC); NCI-H520 (squ-
amous cell carcinoma, SCC); and SW900 (SCC). NHBE and BEAS-
2B cells were grown in BEGM. All lung cancer cell lines were grown
in RPMI 1640 (Gibco BRL, Grand Island, NY) supplemented with
10% fetal bovine serum (HyClone Laboratories, Logan, UT), 100 U/
ml penicillin (Sigma, St. Louis, MO), and 0.1 mg/ml streptomycin
(Sigma).
2.2. Total RNA isolation
Cells grown in monolayer were expanded to approximately 90%
con£uence. Growth medium was removed and the cells were lysed
directly in the culture £ask by treatment with TRI REAGENT (Mo-
lecular Research Center, Cincinnati, OH). Cells grown in suspension
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were sedimented prior to lysis. The resulting cell lysates were snap
frozen in liquid nitrogen and stored at 380‡C. Total RNA was iso-
lated from the lysates by a standard method [14].
2.3. Preparation of an hMTH1 cDNA probe
Total RNA from NHBE cells was reverse-transcribed using the
SuperScript Preampli¢cation System for First Strand cDNA Synthesis
(Gibco BRL). Polymerase chain reaction (PCR) primers correspond-
ing to bases 97^116 (5P-AGCCTCAGCGAGTTCTCCTG-3P) and
248^266 (5P-GATCTGGCCCACCTTGTGC-3P) of the published
hMTH1 cDNA sequence [15] were purchased from Southwest Scien-
ti¢c Resources (Albuquerque, NM). A GeneAmp PCR reagent kit
and AmpliTaq Gold were purchased from Perkin Elmer (Foster
City, CA). A 170 bp amplimer was prepared from 3 Wg ¢rst strand
cDNA. The amplimer was isolated by electrophoresis, ligated into the
pCR2.1 vector and cloned using the TA cloning kit (Invitrogen, Carls-
bad, CA). Dideoxy sequencing con¢rmed that the DNA sequence of
the insert was homologous to the published sequence of hMTH1 [15].
For Northern analysis, 100 ng of hMTH1 cDNA was labeled with K-
32P-dCTP (Amersham, Arlington Heights, IL) using the Random
Primed DNA labeling kit (Boehringer Mannheim, Indianapolis, IN).
Unincorporated K-32P-dCTP was removed by ¢ltration through a Bio-
Spin 30 chromatography column (Bio-Rad, Hercules, CA).
2.4. Northern analysis of hMTH1 mRNA expression
Northern blots were prepared by a standard protocol [16] using
Zeta-Probe nylon membranes (Bio-Rad). The blots were pre-hybrid-
ized in a constant temperature shaking water bath at 65‡C for 4 h
in 100 ml of 250 mM sodium phosphate bu¡er (pH 7.2) containing
7% (w/v) sodium dodecyl sulfate (SDS). The blots were then hybrid-
ized overnight with the 32P-labeled hMTH1 cDNA probe, and
washed at room temperature for 1 h in 1000 ml of 25 mM sodium
phosphate bu¡er (pH 7.2) containing 1% (w/v) SDS. Autoradiographs
were prepared by placing the blots on Kodak BioMax ¢lm at 380‡C.
GAPDH cDNA probe was generously provided by Dr. William A.
Palmisano. Probe labeling and hybridization were as described except
that a second wash was performed at 65‡C for 1 h. Autoradiographs
were scanned into a PC using a £atbed scanner and analyzed using
QuantiScan software (Biosoft, Cambridge, UK).
2.5. DNA isolation, enzymatic digestion and analysis of 8-oxo-dG
Cells grown in monolayer were expanded to approximately 90%
con£uence. Medium was removed and the cells were washed twice
with HBS. NHBE cells were dissociated by adding 0.5 M urea, wash-
ing with HBS, and then adding E-PET (BRFF, Ijamsville, MD) [17].
BEAS-2B cells and lung cancer cells were dissociated by treatment
with trypsin (Sigma). Dissociated cells and cells grown in suspension
were sedimented by centrifugation, washed once with HBS, snap fro-
zen in liquid nitrogen and stored at 380‡C. DNA was isolated from
the cell pellets using a Genomic DNA preparation kit (Qiagen, Va-
lencia, CA) and precipitated with two volumes of 100% ethanol. The
precipitated DNA was washed twice with 70% ethanol, dried under
vacuum, solubilized in deionized water, and quanti¢ed by UV spec-
troscopy. The DNA samples were digested with 20 Wg nuclease P1
(Sigma) in 20 mM sodium acetate bu¡er (pH 5.2) at 37‡C for 30 min
and then treated with 1.3 units of Escherichia coli alkaline phospha-
tase (Sigma) in 100 mM Tris-HCl (pH 7.5) at 37‡C for 60 min [18].
The resulting nucleotide mixture was ¢ltered through a Nalgene sy-
ringe ¢lter (4 mm) and analyzed by HPLC-ECD using a standard
analytical method [19]. Instrument speci¢cations and conditions:
HPLC, Hewlett Packard 1090; UV detector, Hewlett Packard 1040
diode array detector; UV wavelength, 254 nm; EC detector, ESA
Coulochem model 5100A; ESA 5020 guard cell ; EC cell, ESA 5010
analytical cell ; column, Spherisorb ODS2, 5 Wm, 25 cmU4.6 mm;
solvent, 92% (v/v) 50 mM potassium phosphate (pH 5.5)/8% (v/v)
methanol; £ow rate, 1 ml/min. The amount of deoxyguanosine (dG)
was measured by UV absorbance at 245 nm while the amount of 8-
oxo-dG was simultaneously measured by the ECD. The level of 8-
oxo-dG and dG in each DNA sample was determined by peak height
comparison following injection of known quantities of 8-oxo-dG
(Cayman Chemicals) and dG (Sigma) standards.
3. Results
Expression levels of hMTH1 mRNA and GAPDH mRNA
were measured by Northern analysis in NHBE cells, BEAS-2B
cells and 12 lung cancer cell lines (Fig. 1). The numbers shown
in Fig. 1 indicate the ratio of hMTH1 mRNA to GAPDH
mRNA relative to the ratio calculated for NHBE cells. Ele-
vated levels of hMTH1 mRNA were detected in BEAS-2B
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Table 1
Amount of 8-oxo-deoxyguanosine in human lung cells
Cell line Pathologya 8-oxo-dG/105 dGb
NHBE, strain 2129 N 6.35
NHBE, strain 4501 N 4.84
BEAS-2B INT 2.68
A427 AC 2.21
A549 AC 4.00
Calu-3 AC 3.22
SKLU-1 AC 2.72
Calu-6 APC 3.49
Calu-1 EC 3.47
NCI-H82 SC 1.04
NCI-H128 SC 3.46
NCI-H520 SCC 3.00
SW900 SCC 3.56
aAbbreviations for tumor pathology: N, normal; INT, immortalized
non-tumorigenic; AC, adenocarcinoma; APC, anaplastic carcinoma;
EC, epidermoid carcinoma; SC, small cell lung cancer; SCC, squa-
mous cell carcinoma.
bThe number of 8-oxo-deoxyguanosine residues per 105 normal de-
oxyguanosine residues was determined by high pressure liquid
chromatography with electrochemical detection (HPLC-ECD).
Fig. 1. Northern analysis of hMTH1 mRNA expression in NHBE,
BEAS-2B, and human lung cancer cells. Relative Ratio=ratio of
hMTH1 mRNA to GAPDH mRNA relative to this ratio determined
for NHBE cells. Abbreviations for tumor pathology: N, normal;
INT, immortalized non-tumorigenic; AC, adenocarcinoma; EC, epi-
dermoid carcinoma; APC, anaplastic carcinoma; SC, small cell lung
cancer; SCC, squamous cell carcinoma. Identity of cells : top panel
(left to right) NHBE, BEAS-2B, SKLU-1, Calu-3, A427, Calu-1,
and Calu-6; bottom panel (left to right) A549, NCI-H82, NCI-
H128, NCI-H146, NCI-H209, SW900, and NCI-H520.
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cells and 11 out of 12 lung cancer cell lines. One small cell
lung cancer line (NCI-H146) exhibited a lower hMTH1 to
GAPDH mRNA ratio than NHBE cells. Consistent elevated
transcription of the hMTH1 gene was demonstrated by prob-
ing a second set of Northerns that were blotted with RNA
from eight of the same cell lines and four di¡erent cell lines
(data not shown); hMTH1 mRNA was overexpressed in 12
out of 12 lung cancer cell lines (four adenocarcinomas, one
anaplastic carcinoma, one epidermoid carcinoma, and six squa-
mous cell carcinomas). Overall, the gene was overexpressed in
94% (15 out of 16) of lung cancer cell lines evaluated.
Levels of 8-oxo-dG were measured by HPLC-ECD in nu-
cleoside mixtures prepared from DNA of two strains of
NHBE cells (2129, 4501), BEAS-2B cells and 10 lung cancer
cell lines. The results (Table 1) are expressed as the number of
8-oxo-dG residues per 105 normal deoxyguanosine (dG) resi-
dues. The NHBE cells exhibited higher levels of 8-oxo-dG
than BEAS-2B cells and all 10 lung cancer cell lines. The
average value for NHBE cells was 5.60 þ 0.75 (mean þ abso-
lute deviation, n = 2). The average value for the lung cancer
cell lines was 3.02 þ 0.85 (mean þ standard deviation, n = 10).
However, the use of only two di¡erent strains of NHBE cells
precludes the ability to ascribe statistical signi¢cance to these
data. Values of 8-oxo-dG/105 dG (Table 1) were plotted
against hMTH1 to GAPDH mRNA ratios (Fig. 1) to deter-
mine whether there is a relationship between total 8-oxo-dG
levels and hMTH1 mRNA expression. Fig. 2 shows that an
inverse linear relationship (r =30.75) exists between these pa-
rameters.
4. Discussion
The hypothesis of persistent oxidative stress in cancer states
that DNA of certain cancers is persistently exposed to a high-
er level of oxidative stress than that of adjacent normal tissues
[8]. Okamoto et al. [13] have provided support for this hy-
pothesis by showing that hMTH1 mRNA is overexpressed in
renal cell carcinomas and that transcription of this gene in-
creases with clinical stage of the disease. The present study
extends their work to lung cancer. We have measured expres-
sion levels of hMTH1 mRNA relative to GAPDH mRNA in
NHBE cells, BEAS-2B cells, and 12 lung cancer cell lines (Fig.
1). Since elevated levels of GAPDH mRNA have been de-
tected in human lung cancer tissues [20], the use of GAPDH
as a marker when comparing normal and cancer cells results
in a conservative estimate of hMTH1 mRNA overexpression.
Our results show that hMTH1 mRNA levels are elevated in
human lung cancer cell lines (Fig. 1), suggesting that the level
of oxidative stress is indeed elevated in lung cancer cells rel-
ative to NHBE cells. Further, the fact that hMTH1 is over-
expressed in BEAS-2B cells, an SV40-immortalized non-tu-
morigenic human bronchial epithelial cell line, suggests the
exciting possibility that oxidative stress may be a character-
istic of pre-malignant cells.
Levels of 8-oxo-dG were higher in two strains of NHBE
cells than in the BEAS-2B cells and in all 10 of the lung
cancer cell lines analyzed (Table 1). This is in contrast to
previous studies where elevated levels of 8-oxo-dG were de-
tected in primary lung tumor samples [5,6]. The disparity be-
tween these results may be due to overestimation of 8-oxo-dG
levels in the primary tumors due to the GC/MS method used
in these two studies, but it is impossible to con¢rm this pos-
sibility since the HPLC-ECD method has not been used to
measure 8-oxo-dG levels in primary human lung tumors.
However, the HPLC-ECD method has been used by Barcis-
zewski et al. [21] to measure 8-oxo-dG levels in normal and
SV40-immortalized human ¢broblasts in culture; the trans-
formed cells were reported to have 2.1 residues of 8-oxo-dG
per 105 dG residues while the normal cells had ¢ve-fold higher
levels of 8-oxo-dG. Our data with BEAS-2B cells and NHBE
cells show similar results (Table 1); the level of 8-oxo-dG in
BEAS-2B cells is lower than in either of two strains of NHBE
cells. In contrast, levels of 8-oxo-dG determined by the GC/
MS method in HPV-immortalized human bronchial epithelial
cells [22,23] are more than an order of magnitude higher than
either our values or those of Barciszewski et al. [21]. These
di¡erences suggest that either the GC/MS method overesti-
mates 8-oxo-dG levels in cultured cells or that the HPLC-
ECD method underestimates these levels [24].
The fact that hMTH1 mRNA expression is 2.2-fold higher
in BEAS-2B cells compared to NHBE cells (Fig. 1) suggests
that the di¡erences in 8-oxo-dG levels between these cells
(Table 1) can be ascribed to higher DNA repair e⁄ciency of
the immortalized cells. This was the conclusion drawn by
Barciszewski et al. [21] after observing: (1) lower levels of 8-
oxo-dG in DNA from immortalized ¢broblasts compared to
normal ¢broblasts; and (2) no di¡erence in the amount of 8-
oxo-dG in culture media collected from normal and trans-
formed ¢broblasts. Instead of decreased misincorporation of
8-oxo-dGTP into DNA, their results seem to suggest that the
e⁄ciency of removal of 8-oxo-dG from DNA is enhanced,
perhaps via up-regulation of human homologues of mutM
and mutY genes [10]. However, measurement of 8-oxo-dG in
culture media does not di¡erentiate between 8-oxo-dGTP and
8-oxo-dGMP, the substrate and product of the hMTH1 en-
zyme. Therefore, 8-oxo-dG can only be used as a marker of
oxidative DNA damage and not as an indicator of the e⁄-
ciency of DNA repair.
A plot of 8-oxo-dG values against hMTH1 expression (Fig.
2) shows the relationship between these two parameters in
human lung cancer cell lines. The plot shows an inverse linear
correlation between these parameters, suggesting that up-reg-
ulation of hMTH1 gene expression protects the integrity of
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Fig. 2. Relationship between 8-oxo-deoxyguanosine levels and
hMTH1 expression for human lung cancer cells.
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cancer cell DNA by preventing misincorporation of 8-oxo-
dGTP into DNA, thereby reducing the detectable level of 8-
oxo-dG. These results are in agreement with Okamoto et al.
[13] who found that hMTH1 mRNA expression increased
with clinical stage of renal cell carcinoma while 8-oxo-dG
levels remained relatively constant [7]. Thus, the level of oxi-
dative stress in renal cell carcinomas increases with the clinical
stage of the disease; however, the cells apparently up-regulate
expression of hMTH1 in response to increased oxidative stress
and thereby keep 8-oxo-dG levels relatively constant through-
out the course of the disease. Our results suggest that the
same type of protective mechanism is active in BEAS-2B cells
and lung cancer cell lines.
Future work in our laboratory will examine the association
between hMTH1 mRNA levels, hMTH1 protein levels, 8-oxo-
dGTPase activity and 8-oxo-dG levels in NHBE cells and lung
cancer cell lines. Ultimately, hMTH1 expression will be used
to investigate the temporal relationship between oxidative
stress, genomic instability and the development of lung can-
cer.
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